Detalhe da pesquisa
1.
Pharmacokinetic models for first-in-human dose selection of immune-activating products in oncology.
Regul Toxicol Pharmacol
; 149: 105616, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561147
2.
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
Lancet Oncol
; 24(10): e415-e423, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37797647
3.
Access to internet, smartphone usage, and acceptability of mobile health technology among cancer patients.
Support Care Cancer
; 28(11): 5455-5461, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32166381
4.
An FDA analysis of clinical hold deficiencies affecting investigational new drug applications for oncology products.
Regul Toxicol Pharmacol
; 110: 104511, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31678263
5.
An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates.
Regul Toxicol Pharmacol
; 107: 104429, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325532
6.
Trends and Outcomes of Venous Thromboembolism in Hospitalized Patients With Ovarian Cancer: Results From Nationwide Inpatient Sample Database 2003 to 2011.
Int J Gynecol Cancer
; 28(8): 1478-1484, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045139
7.
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection.
Regul Toxicol Pharmacol
; 90: 144-152, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28887049
8.
An FDA oncology analysis of immune activating products and first-in-human dose selection.
Regul Toxicol Pharmacol
; 81: 448-456, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27743776
9.
An FDA oncology analysis of antibody-drug conjugates.
Regul Toxicol Pharmacol
; 71(3): 444-52, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25661711
10.
Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer.
Cancer
; 119(11): 1941-50, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23504768
11.
The Comparison of Gender Dysphoria, Body Image Satisfaction and Quality of Life Between Treatment-Naive Transgender Males With and Without Polycystic Ovary Syndrome.
Transgend Health
; 7(6): 514-520, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644121
12.
FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer.
Clin Cancer Res
; 28(19): 4173-4177, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35679021
13.
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer.
Clin Cancer Res
; 28(8): 1487-1492, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916216
14.
An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs.
Regul Toxicol Pharmacol
; 79: 142-143, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26952647
15.
FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer.
Clin Cancer Res
; 27(9): 2378-2382, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33288660
16.
Panel discussion: alternative mouse models for carcinogenicity assessment.
Toxicol Pathol
; 38(1): 72-5, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19884653
17.
Summary of a workshop on preclinical and translational safety assessment of CD3 bispecifics.
J Immunotoxicol
; 17(1): 67-85, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32100588
18.
Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies.
Clin Cancer Res
; 14(14): 4378-84, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18628451
19.
Tasigna for chronic and accelerated phase Philadelphia chromosome--positive chronic myelogenous leukemia resistant to or intolerant of imatinib.
Clin Cancer Res
; 14(17): 5325-31, 2008 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18765523
20.
An overview and history of interpersonal psychotherapy.
Nurs Stand
; 23(26): 44-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19323110